Zaman, F.Y.; Subramaniam, A.; Afroz, A.; Samoon, Z.; Gough, D.; Arulananda, S.; Alamgeer, M.
Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis. Cancers 2023, 15, 2425.
https://doi.org/10.3390/cancers15092425
AMA Style
Zaman FY, Subramaniam A, Afroz A, Samoon Z, Gough D, Arulananda S, Alamgeer M.
Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis. Cancers. 2023; 15(9):2425.
https://doi.org/10.3390/cancers15092425
Chicago/Turabian Style
Zaman, Farzana Y., Ashwin Subramaniam, Afsana Afroz, Zarka Samoon, Daniel Gough, Surein Arulananda, and Muhammad Alamgeer.
2023. "Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis" Cancers 15, no. 9: 2425.
https://doi.org/10.3390/cancers15092425
APA Style
Zaman, F. Y., Subramaniam, A., Afroz, A., Samoon, Z., Gough, D., Arulananda, S., & Alamgeer, M.
(2023). Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis. Cancers, 15(9), 2425.
https://doi.org/10.3390/cancers15092425